ARTICLE SUMMARY:
Among the 2023 MedTech Innovator award winners are two companies working in stroke, from opposite ends of the treatment spectrum. StrokeDx has a point-of-care diagnostic for the hospitalized acute stroke patient, and MicroTransponder restores lost abilities to chronic stroke patients, even years after the event.
MedTech Innovator officially ended its 2023 cohort with the announcement of awards presented to innovative medtech companies in its accelerator program. In each category, the best of the best were chosen by a live audience after a pitch competition (see Figure 1). In the US, out of 1,200 applications received for the MedTech Innovation accelerator in 2023, the funnel narrowed to 200 companies invited to pitch, then to a select 61 that gained entry to the MedTech Innovator accelerator, which offers companies not only a peer group of medtech start-up CEOs facing many of the same challenges, but a network of strategics, investors, regulatory experts, and just about any resource a medtech start-up might need. (See, “MedTech Innovator: Mentorship and Its Multiplying Effect on Medtech,” MedTech Strategist, September 14, 2023).
We feature two of the top winners in separate articles this month: StrokeDx and MicroTransponder, both focusing on stroke care. StrokeDx received the highest honor, a $350,000 award as the grand prize winner of the Global Competition, with MicroTransponder garnering $200,000 as the winner of the first ever competition honoring mid-stage companies.
